Sino Biopharmaceutical Limited
SBMFF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $9,569,584 | $9,451,878 | $8,654,805 | $9,599,537 |
| Short-Term Investments | $5,027,688 | $1,553,257 | $8,266,858 | $6,194,514 |
| Receivables | $5,012,638 | $4,596,202 | $4,643,443 | $4,285,239 |
| Inventory | $2,373,145 | $1,993,472 | $2,328,844 | $1,937,741 |
| Other Curr. Assets | $2,702,276 | $3,097,682 | $2,040,955 | $1,486,147 |
| Total Curr. Assets | $24,685,331 | $23,805,531 | $25,934,905 | $23,503,178 |
| Property Plant & Equip (Net) | $10,288,156 | $9,912,161 | $9,251,183 | $8,516,062 |
| Goodwill | $915,689 | $680,452 | $662,611 | $647,930 |
| Intangibles | $2,145,277 | $248,491 | $1,251,839 | $1,064,016 |
| Long-Term Investments | $26,336,532 | $25,180,970 | $16,962,725 | $18,974,971 |
| Tax Assets | $0 | $0 | $505,148 | $334,865 |
| Other NC Assets | $1,037,084 | $3,777,214 | $9,495,873 | $7,502,315 |
| Total NC Assets | $40,722,738 | $39,799,288 | $38,129,379 | $37,040,159 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $65,408,069 | $63,604,819 | $64,064,284 | $60,543,337 |
| Liabilities | – | – | – | – |
| Payables | $1,497,461 | $1,334,703 | $1,883,800 | $1,794,684 |
| Short-Term Debt | $7,703,696 | $11,207,428 | $9,723,841 | $6,585,038 |
| Tax Payable | $0 | $516,012 | $330,888 | $343,650 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10,355,333 | $9,548,632 | $8,212,148 | $6,621,647 |
| Total Curr. Liab. | $19,556,490 | $22,606,775 | $20,150,677 | $15,345,019 |
| LT Debt | $2,080,145 | $1,372,816 | $4,258,122 | $5,532,475 |
| Deferred Rev, NC | $0 | $548,272 | $749,070 | $674,450 |
| Deferred Tax Liab, NC | $0 | $781,543 | $831,791 | $881,590 |
| Other NC Liab. | $997,364 | $125,460 | $131,076 | $380,780 |
| Total NC Liab. | $3,077,509 | $2,828,091 | $5,970,059 | $7,469,295 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $111,726 | $369,882 | $384,694 | $384,422 |
| Total Liabilities | $22,633,999 | $25,434,866 | $26,120,736 | $22,814,314 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $5,686,141 | $10,077,772 | $0 |
| Common Stock | $414,384 | $414,615 | $414,899 | $415,440 |
| Retained Earnings | $25,280,560 | $23,648,943 | $23,069,898 | $27,214,610 |
| AOCI | $0 | -$9,948,506 | -$10,077,772 | -$9,227,928 |
| Other Equity | $6,265,845 | $10,673,276 | $6,284,929 | $11,888,994 |
| Total Equity | $31,960,789 | $30,474,469 | $29,747,035 | $30,291,116 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $10,813,281 | $7,695,484 | $8,196,513 | $7,437,907 |
| Total Liab. & Tot. Equity | $65,408,069 | $63,604,819 | $64,064,284 | $60,543,337 |
| Net Debt | $214,257 | $3,128,366 | $5,327,158 | $2,517,976 |